我国医药行业知识产权侵权纠纷多元解决机制的建立与发展  

The establishment and development of multiple resolution mechanism of intellectual property infringement disputes in China's pharmaceutical industry

作　　者：朱珈震 李静 张静 ZHU Jia-zhen;LI Jing;ZHANG Jing(School of Science,China Pharmaceutical University,Nanjing 211198,China;Library and Information Center,China Pharmaceutical University,Nanjing 211198,China;Journal Editorial Department,China Pharmaceutical University,Nanjing 210009,China)

机构地区：[1]中国药科大学理学院,南京211198 [2]中国药科大学图书与信息中心,南京211198 [3]中国药科大学期刊编辑部,南京210009

出　　处：《中国新药杂志》2024年第13期1303-1310,共8页Chinese Journal of New Drugs

摘　　要：近年来我国涉及医药行业的知识产权侵权纠纷案件快速增加,只采用诉讼的方式并不能彻底满足当事人解决纠纷的需求,因此出现了针对专利侵权纠纷的多元解决机制,为专利侵权案件的双方当事人提供便利、多样、有效的专利侵权纠纷解决途径。其中药品专利纠纷早期解决机制的全面实施平衡了我国创新药和仿制药的发展,有利于我国医药行业的创新发展。本文通过对相关文献进行分析,阐述我国医药行业所处的环境,针对当前环境采用的多元纠纷解决机制的不足提出建议。In recent years, the number of intellectual property infringement disputes in the pharmaceutical industry of China has increased rapidly, but litigation alone cannot completely meet the needs of the parties to resolve disputes. Therefore, a diversified resolution mechanism for intellectual property infringement disputes has emerged, providing convenient, efficient and diversified ways to resolve patent infringement disputes for both parties of intellectual property infringement cases. The comprehensive implementation of the early resolution mechanism for drug patent disputes has balanced the development of innovative and generic drugs, which can be more conducive to the innovative development of China's pharmaceutical industry. This article analyzes the relevant literature, describes the environment of China's pharmaceutical industry and the diversified dispute resolution mechanism adopted in China for the current environment.

关 键 词：专利侵权纠纷 知识产权 医药行业 专利纠纷早期解决 

分 类 号：R95[医药卫生—药学]